IL3 and chronic myelogenous leukemia, BCR-ABL1 positive: Nonetheless, our validation experiments and literature data indicate that several genes of this list are aberrantly expressed, for example IL‐3 that is produced by CML cells and a therapeutic target (Frolova et al., 2014; Jiang et al., 1999).